Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Single cell analysis has become of great interest with exceptional capabilities for the systematic investigation of cell-to-cell variation in large populations. Rapid and multi-parametric analysis of intercellular biomolecules at the single-cell level is imperative for the improvement of early disease diagnosis and personalized medicine. Although still largely confined to a subset of devoted researchers, single-cell analysis is starting to enjoy wider use, growing as single-cell platforms become more accessible, as expertise is gained and disseminated, and as diverse methodologies gel. And therefore, although this market is at the infant stage in current space, it exhibits the potential to improve the accuracy and specificity of disease diagnosis based on knowledge of inter- and intra-cellular networks. Moreover, emerging trend for implementation of circulating tumor cells-based cancer diagnostics is anticipated to spur the revenue share of diagnostics in the forthcoming years.
The increasing incidence of the chronic disorder such as cancer is the major driving factor for the growth of the market. As indicated by National Institutes of Health (NIH), in 2018, a projected 1,735,350 new cases of cancer will be identified in the United States and 609,640 people will die from the disease. Since the single cell sequencing analysis has found its application in search of better diagnostic and prognostic biomarkers, it is likely to drive the growth of the market. Besides, swiftly evolving omics market, in the U.S. has led to the high demand of the single cell analysis technique . Moreover, strong funding agencies in the U.S coupled with the presence of major players engaged in delivering high-throughput technologies will drive the growth of the market.
The impact of the COVID-19 pandemic is very wide and occupies almost every aspect of life across the world with the wave of direct health impacts cutting across each nation at different paces. The impact on the economies of all countries has been dramatic and has yet to become fully apparent. Laboratory research and research based on experimental models were significantly impacted by university directed ramping down of nonessential research. However, the outbreak of COVID-19 is expected to have a minimal or negligible impact on the single cell analysis market. The rise in the incidences of COVID has led to an increase in the need for an efficient drug or vaccine for COVID, which could help in reducing the severity of the cases. Cell-based research is an essential step during the manufacturing of vaccines, which can help in the growth of the market.
The single-cell analysis market is analysed based on product, cell type, application and end user. The major products that are required for conducting single cell analysis consists of various types of consumables and instruments. Consumables of single cell analysis are accessible as of beads, microplates, reagents, assay kits etc. Whereas, single cell analysis instruments incorporate flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems and microarrays. These products are used for single cell analysis of different cell types including human cells, animal cells and microbial cells. The single cell analysis market finds application in research and medical applications. Single cell analysis is being researched and employed across various end-use settings including academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and cell banks & IVF centers.
Some of the major players operating in the global single cell analysis market include Becton, Dickinson and Company, Danaher Corporation, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc., General Electric Company, 10x Genomics, Promega Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Nanostring Technologies, Inc., Sartorius AG, Luminex Corporation and Fluxion Biosciences among others.
The report analyses the single cell analysis market based on product, call type, application, end user and countries. Single cell analysis products includes instruments and consumables. Various consumables required for single cell analysis consists of beads, microplates, reagents, assay kits etc. instruments incorporates flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems and microarrays. The major applications of the market includes research and medical application. The major end users of the market includes academic & research laboratories, biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories and cell banks & IVF centers.
Some of the major players opening in this region include Becton, Dickinson and Company, Danaher Corporation, Merck Millipore, Qiagen N.V., Thermo Fisher Scientific, Inc., General Electric Company, 10x Genomics, Promega Corporation, Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Nanostring Technologies, Inc., Sartorius AG, Luminex Corporation and Fluxion Biosciences among others..
Why to Buy This Report
